Biological
Stem Cell clinical trials
- studies test it
- 76
- open now
- 7
- in phase 3
- 4
- first study started
- 1999
Keep track of what changes. Save the Stem Cell studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
76 studies that test it; most in 2008 (6)
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2001 | 1 |
| 2005 | 2 |
| 2008 | 6 |
| 2009 | 3 |
| 2010 | 5 |
| 2011 | 4 |
| 2012 | 6 |
| 2013 | 5 |
| 2014 | 6 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 6 |
| 2018 | 5 |
| 2019 | 1 |
| 2020 | 5 |
| 2021 | 5 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 48
- Phase 2
- 41
- Phase 3
- 4
- Phase 4
- 2
- No phase
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 65
Neurogen Brain and Spine Institute (8) · Joshua M Hare (5) · Stem Cells Arabia (4) · Rigshospitalet, Denmark (3) · Al-Azhar University (3) · St. Jude Children's Research Hospital (2) · Honya Medical Inc (2) · Masonic Cancer Center, University of Minnesota (2)
Often tested with
Tested in the same studies.
Melphalan (3) · Fludarabine (2) · Busulfan (2) · Rituximab (1) · Platelet rich plasma (1) · Alemtuzumab (1) · Treosulfan (1) · Clofarabine (1)
Studies
Open first, then newest update. How each study uses Stem Cell is read from its arms, and is right about nine times in ten.
Testing it · 76
- A Study to Investigate Small Mobile Stem Cells (SMS) in Moderate to Severe Chronic Obstructive Pulmonary DiseaseNot yet recruitingPhase 1/2SMSbiotechNCT07871890Written as Stem cells
- Investigation of Small Mobile Stem Cells (SMS Cells) in Participants With Chronic Obstructive Pulmonary Disease (COPD).RecruitingPhase 1SMSbiotechNCT06986070Written as Stem cells
- Mesenchymal Stem Cells in the Treatment of Burn WoundsRecruitingNot applicableThe First Affiliated Hospital of Xinxiang Medical CollegeNCT07580755Written as low-dose stem cell gel group
- MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological DiseasesRecruitingPhase 2Masonic Cancer Center, University of MinnesotaNCT07493538Written as Stem Cell Infusion
- MCRcI® Stem Cell Treatment for Diffuse Coronary Artery DiseaseNot yet recruitingPhase 1Honya Medical IncNCT04052191Written as MCRcI® stem cells
- Stem Cell Applications in Biliary Atresia PatientsRecruitingNot applicableNecmi Kadıoğlu HospitalNCT06564740Written as Stem Cell
- Stem Cell Study for Long COVID-19 Neurological SymptomsNot yet recruitingPhase 1Charles CoxNCT06156241Written as Stem Cell
- Impact of Mesenchymal Stem Cells in Knee OsteoarthritisCompletedPhase 1University Hospitals Cleveland Medical CenterNCT03477942Written as Autologous Mesenchymal Stem Cells
- Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD)CompletedPhase 1/2Joshua M HareNCT04776239Written as 100 million Allogeneic Mesenchymal Human Stem Cells
- A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and LymphomasCompletedPhase 1St. Jude Children's Research HospitalNCT01625351Written as stem cells
- CNS10-NPC for the Treatment of RPActive, not recruitingPhase 1Cedars-Sinai Medical CenterNCT04284293Written as CNS10-NPC implantation
- Autologous Stem Cell Study for Adult TBI (Phase 2b)Active, not recruitingPhase 2The University of Texas Health Science Center, HoustonNCT02525432Written as Autologous BMMNC Infusion
- MiSaver® Stem Cell Treatment for Heart Attack (Acute Myocardial Infarction)CompletedPhase 1/2Honya Medical IncNCT04050163Written as MiSaver®
- Safety and Efficacy of Mesenchymal Stem Cell for Radiation-induced Hyposalivation and Xerostomia in Previous Head and Neck Cancer PatientsActive, not recruitingPhase 2Rigshospitalet, DenmarkNCT04776538Written as Stem cells
- Knee Osteoarthritis Treatment With Adipose-derived Stem Cells: Phase II Clinical TrialCompletedPhase 2King Faisal Specialist Hospital & Research Centre, JeddahNCT03308006Written as Stem cells
- MSCs For Treatment of Azoospermic PatientsCompletedPhase 1/2Al-Azhar UniversityNCT02025270Written as Stem Cells
- Allogeneic Mesenchymal Human Stem Cells Infusion Therapy for Endothelial DySfunctiOn in Diabetic SubjectsCompletedPhase 1/2Joshua M HareNCT02886884Written as 20 million Allogeneic Mesenchymal Human Stem Cells
- The Outcomes of Intracavernosal Umbilical Cord Mesenchymal Stem Cells Implantation in Patients With Diabetic Erectile DysfunctionStatus unknownPhase 2/3Indonesia UniversityNCT04972890Written as stem cells
- Stem Cells and Stromal Vascular Fraction for Temporomandibular Joint DiseaseStatus unknownPhase 1/2TC Erciyes UniversityNCT05305833Written as Stem Cells
- Treatment of Breast Cancer-related Lymphedema With Stem Cells and Fat GraftingCompletedPhase 2Odense University HospitalNCT03776721Written as Stem cell injection
See all 76 studies that test Stem Cell →
Given in every arm · 3 — Stem Cell is usual care beside what is tested
- Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With AD-MSCs in PsoriasisRecruitingPhase 1/2Guangdong Provincial Hospital of Traditional Chinese MedicineNCT04785027Written as adipose-derived multipotent mesenchymal stem cells
- Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)CompletedPhase 2M.D. Anderson Cancer CenterNCT02441803Written as Stem Cell Infusion
- Rituxan + BEAM and Auto Stem Cell Transplant for High Risk Lymphoma or Hodgkin's DiseaseCompletedNot applicableBaylor College of MedicineNCT01702961Written as Stem Cells